Reuters logo
WuXi PharmaTech's IPO prices at $14 per ADS
August 9, 2007 / 2:52 AM / 10 years ago

WuXi PharmaTech's IPO prices at $14 per ADS

NEW YORK, Aug 8 (Reuters) - An initial public offering by WuXi PharmaTech (Cayman) Inc. priced at $14 per American Depositary Share, the company said on Wednesday.

The offering was 13.2 million ADS.

Credit Suisse, JPMorgan and Jefferies & Co. underwrote the offering of the China-based pharmaceutical and biotechnology research and development outsourcing company.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below